Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$209.01 - $232.56 $613,235 - $682,331
2,934 Added 2.63%
114,488 $25 Million
Q4 2023

Feb 14, 2024

SELL
$197.69 - $227.29 $1.12 Million - $1.29 Million
-5,680 Reduced 4.85%
111,554 $25.4 Million
Q3 2023

Nov 14, 2023

SELL
$201.05 - $221.7 $85,245 - $94,000
-424 Reduced 0.36%
117,234 $23.6 Million
Q2 2023

Aug 14, 2023

BUY
$211.93 - $241.33 $6,781 - $7,722
32 Added 0.03%
117,658 $28.4 Million
Q1 2023

May 15, 2023

SELL
$213.32 - $257.83 $3.96 Million - $4.78 Million
-18,553 Reduced 13.62%
117,626 $27 Million
Q4 2022

Feb 14, 2023

BUY
$203.72 - $248.97 $3.71 Million - $4.53 Million
18,189 Added 15.42%
136,179 $32.1 Million
Q3 2022

Nov 14, 2022

SELL
$204.81 - $262.19 $166 Million - $212 Million
-808,383 Reduced 87.26%
117,990 $24.2 Million
Q2 2022

Aug 15, 2022

SELL
$213.86 - $277.87 $202 Million - $262 Million
-942,671 Reduced 50.44%
926,373 $217 Million
Q1 2022

May 16, 2022

BUY
$259.82 - $298.18 $448 Million - $514 Million
1,725,182 Added 1199.19%
1,869,044 $493 Million
Q4 2021

Feb 14, 2022

SELL
$271.6 - $314.21 $2.23 Million - $2.58 Million
-8,201 Reduced 5.39%
143,862 $45.2 Million
Q3 2021

Nov 15, 2021

SELL
$274.82 - $308.34 $424,322 - $476,076
-1,544 Reduced 1.01%
152,063 $42.8 Million
Q2 2021

Aug 16, 2021

BUY
$251.87 - $278.14 $51,129 - $56,462
203 Added 0.13%
153,607 $42.4 Million
Q1 2021

May 17, 2021

SELL
$204.88 - $255.03 $2.02 Million - $2.51 Million
-9,836 Reduced 6.03%
153,404 $39.1 Million
Q4 2020

Feb 16, 2021

BUY
$186.91 - $214.42 $30.5 Million - $35 Million
163,240 New
163,240 $33.2 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.